{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:37:20Z","timestamp":1751395040056,"version":"3.40.4"},"reference-count":26,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ejphar.2014.01.062","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T18:47:04Z","timestamp":1391626024000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Risperidone inhibits voltage-gated sodium channels"],"prefix":"10.1016","volume":"728","author":[{"given":"Jan M.","family":"Brauner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Hessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teja W.","family":"Groemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Alzheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Huth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.01.062_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1176\/appi.ps.57.12.1693","article-title":"Antipsychotic use and expenditure in the United States","volume":"57","author":"Aparasu","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ejphar.2014.01.062_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1085\/jgp.81.5.613","article-title":"Lidocaine block of cardiac sodium channels","volume":"81","author":"Bean","year":"1983","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1085\/jgp.113.2.333","article-title":"Augmentation of recovery from inactivation by site-3 Na channel toxins. A single-channel and whole-cell study of persistent currents","volume":"113","author":"Benzinger","year":"1999","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0026-895X(25)08936-9","article-title":"Gate-dependent blockade of sodium channels by phenothiazine derivatives: structure-activity relationships","volume":"42","author":"Bolotina","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2006.04.025","article-title":"Molecular diversity of voltage-gated sodium channel alpha and beta subunit mRNAs in human tissues","volume":"541","author":"Candenas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib6","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1113\/jphysiol.2011.224204","article-title":"Voltage-gated sodium channels at 60: structure, function and pathophysiology","volume":"590","author":"Catterall","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11095-006-0070-7","article-title":"Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","author":"Crumb","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2014.01.062_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1113\/jphysiol.2003.047357","article-title":"Distinct repriming and closed-state inactivation kinetics of NaV1.6 and NaV1.7 sodium channels in mouse spinal sensory neurons","volume":"551","author":"Herzog","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00424-008-0500-y","article-title":"Four-mode gating model of fast inactivation of sodium channel NaV1.2a","volume":"457","author":"Huth","year":"2008","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.ejphar.2014.01.062_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0021-5155(97)00042-7","article-title":"Haloperidol effects on Na current in acutely isolated rat retinal ganglion cells","volume":"41","author":"Ito","year":"1997","journal-title":"Japan. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/mol.110.070276","article-title":"Inhibition of neuronal voltage-gated sodium channels by brilliant blue G","volume":"80","author":"Jo","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(25)38428-4","article-title":"Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells","volume":"266","author":"Lang","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.01.062_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/mol.106.024034","article-title":"Subtype specificity of scorpion beta-toxin Tz1 interaction with voltage-gated sodium channels is determined by the pore loop of domain 3","volume":"70","author":"Leipold","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib14","doi-asserted-by":"crossref","first-page":"e15568","DOI":"10.1371\/journal.pone.0015568","article-title":"Classification of drugs based on properties of sodium channel inhibition: a comparative automated patch-clamp study","volume":"5","author":"Lenkey","year":"2010","journal-title":"PLOS One"},{"key":"10.1016\/j.ejphar.2014.01.062_bib15","series-title":"Single-Channel Recording","article-title":"Tight-seal whole-cell recording","author":"Marty","year":"1995"},{"key":"10.1016\/j.ejphar.2014.01.062_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.01.062_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1990.sp017906","article-title":"Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells","volume":"420","author":"Ogata","year":"1990","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib18","first-page":"756","article-title":"Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs","volume":"40","author":"Ragsdale","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib19","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1152\/jn.90332.2008","article-title":"Role of axonal NaV1.6 sodium channels in action potential initiation of CA1 pyramidal neurons","volume":"100","author":"Royeck","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2014.01.062_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"year":"2012","series-title":"Arzneiverordnungs Report","author":"Schwabe","key":"10.1016\/j.ejphar.2014.01.062_bib21"},{"key":"10.1016\/j.ejphar.2014.01.062_bib22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuron.2012.04.019","article-title":"Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs","volume":"74","author":"Tischbirek","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2014.01.062_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-0270(98)00140-X","article-title":"Software-based correction of single compartment series resistance errors","volume":"86","author":"Traynelis","year":"1998","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2014.01.062_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0006-8993(89)90607-0","article-title":"Effects of chlordiazepoxide, chlorpromazine, diazepam, diphenylhydantoin, flunitrazepam and haloperidol on the voltage-dependent sodium current of isolated mammalian brain neurons","volume":"494","author":"Wakamori","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.01.062_bib25","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1523\/JNEUROSCI.0541-05.2005","article-title":"Voltage-gated sodium channel NaV1.6 is modulated by p38 mitogen-activated protein kinase","volume":"25","author":"Wittmack","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.01.062_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/syn.20123","article-title":"Effects of haloperidol and clozapine on glutamate release from nerve terminals isolated from rat prefrontal cortex","volume":"56","author":"Yang","year":"2005","journal-title":"Synapse"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T19:44:19Z","timestamp":1746128659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":26,"alternative-id":["S0014299914000983"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.062","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risperidone inhibits voltage-gated sodium channels","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}